Recent studies show scientific evidence supporting the potential of using psychedelics to treat mental health disorders like generalized anxiety disorder (GAD).
Low clinical trial participation among the Black community is fueled by things like mistrust of the medical system, economic inequities, and a lack of awareness about the trials themselves. One woman started a foundation change all that.
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
In an unusual post-midnight statement, the National Institute of Allergy and Infectious Diseases said AstraZeneca might have used old data for its COVID-19 vaccine trial.
Some pharmaceutical companies are well into the final phase of clinical trials for a coronavirus vaccine. But efforts to recruit patients from minority groups are just beginning.